IL6 and hematologic disorder: Additionally, maximum levels of the proinflammatory cytokine IL‐6 were higher in patients with hematological malignancies compared to solid tumors, indicating a more pronounced inflammatory response in these patients, although IL‐6 levels at diagnosis of Covid‐19 were comparable between those two cohorts and the noncancer patients.